Clinical Trial Site

Shanghai 200032

2 studies enrolling now · 2 studies all time

What they study most

AQP4+ NMOSD, High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension, NMOSD, Neuromyelitis Optica Spectrum Disorder

Studies at this site

• Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease — Recruiting now
• Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies — Recruiting now